Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Asensi, 2002, Inhibition of cancer growth by resveratrol is related to its low bioavailability, Free Rad. Biol. Med., 33, 387, 10.1016/S0891-5849(02)00911-5
Baker, 1987, Pharmacologic role of cysteine in ameliorating or exacerbating mineral toxicities, J. Nutr., 117, 1003, 10.1093/jn/117.6.1003
Baur, 2006, Resveratrol improves health and survival of mice on a high-calorie diet, Nature, 444, 337, 10.1038/nature05354
Beal, 2005, Mitochondria take center stage in aging and neurodegeneration, Ann. Neurol., 58, 495, 10.1002/ana.20624
Belguendouz, 1997, Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins, Biochem. Pharmacol., 53, 1347, 10.1016/S0006-2952(96)00820-9
Bertelli, 1998, Stability of resveratrol over time and in the various stages of grape transformation, Drugs Under Exp. Clin. Res., 24, 207
Bubber, 2005, Mitochondrial abnormalities in Alzheimer brain: mechanistic implications, Ann. Neurol., 57, 695, 10.1002/ana.20474
Butterfield, 1994, Beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease, Biochem. Biophys. Res. Commun., 200, 710, 10.1006/bbrc.1994.1508
Cakir, 2001, Synthesis, spectroscopic and voltammetric studies of mixed-ligand copper(II) complexes of amino acids, Trans. Met. Chem., 26, 89, 10.1023/A:1007119907894
Chen, 2003, Zinc toxicity on neonatal cortical neurons: involvement of glutathione chelation, J. Neurochem., 85, 443, 10.1046/j.1471-4159.2003.01691.x
Chen, 1989, The effect of aging on glutathione and cysteine levels in different regions of the mouse brain, Proc. Soc. Exp. Biol. Med., 190, 399, 10.3181/00379727-190-42879
Chen, 2007, Study on the stability of resveratrol in rhizoma polygoni cuspidati, Zhong Yao Cai, 30, 805
Cherny, 2001, Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice, Neuron, 30, 665, 10.1016/S0896-6273(01)00317-8
Chishti, 2001, Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695, J. Biol. Chem., 276, 21562, 10.1074/jbc.M100710200
Conte, 2003, Synergistic protection of PC12 cells from beta-amyloid toxicity by resveratrol and catechin, Brain Res. Bull., 62, 29, 10.1016/j.brainresbull.2003.08.001
Dasgupta, 2007, Resveratrol stimulates AMP kinase activity in neurons, Proc. Natl. Acad. Sci. U.S.A., 104, 7217, 10.1073/pnas.0610068104
Engelhart, 2002, Dietary intake of antioxidants and risk of Alzheimer disease, J. Am. Med. Assoc., 287, 3223, 10.1001/jama.287.24.3223
Frankel, 1993, Inhibition of human LDL oxidation by resveratrol, Lancet, 341, 1103, 10.1016/0140-6736(93)92472-6
Fremont, 1999, Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids, Life Sci., 64, 2511, 10.1016/S0024-3205(99)00209-X
Gibson, 2000, Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype, Ann. Neurol., 48, 297, 10.1002/1531-8249(200009)48:3<297::AID-ANA3>3.0.CO;2-Z
Gibson, 2005, The alpha-ketoglutarate-dehydrogenase complex: a mediator between mitochondria and oxidative stress in neurodegeneration, Mol. Neurobiol., 31, 43, 10.1385/MN:31:1-3:043
Hallman, 1971, The computed distribution of copper(II) and zinc(II) ions among seventeen amino acids present in human blood plasma, Biochem. J., 121, 549, 10.1042/bj1210549
Hensley, 1994, A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A., 91, 3270, 10.1073/pnas.91.8.3270
Huang, 1999, Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction, J. Biol. Chem., 274, 37111, 10.1074/jbc.274.52.37111
Jang, 2003, Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death, Free Radical Biology & Medicine, 34, 1100, 10.1016/S0891-5849(03)00062-5
Juan, 1999, Determination of trans-resveratrol in plasma by HPLC, Anal. Chem., 71, 747, 10.1021/ac9808831
Karuppagounder, 2007, Changes in inflammatory processes associated with selective vulnerability following mild impairment of oxidative metabolism, Neurobiol. Dis., 26, 353, 10.1016/j.nbd.2007.01.011
Karuppagounder, S.S., Xu, H., Shi, Q., Chen, L.H., Pedrini, S., Pechman, D.P., Baker, H.A., Beal, M.F., Gandy, S.E., Gibson, G.E., 2008. Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer's mouse model. Neurobiol. Aging, doi: 10.1016/j.neurobiolaging.2007.12.013.
Kim, 2007, SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis, EMBO J., 26, 3169, 10.1038/sj.emboj.7601758
Kim, 2007, Protective effects of piceatannol against beta-amyloid-induced neuronal cell death, Ann. N. Y. Acad. Sci., 1095, 473, 10.1196/annals.1397.051
Kuhnle, 2000, Resveratrol is absorbed in the small intestine as resveratrol glucuronide, Biochem. Biophys. Res. Commun., 272, 212, 10.1006/bbrc.2000.2750
Lagouge, 2006, Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha, Cell, 127, 1109, 10.1016/j.cell.2006.11.013
Lakritz, 1997, Validated high-performance liquid chromatography–electrochemical method for determination of glutathione and glutathione disulfide in small tissue samples, Anal. Biochem., 247, 63, 10.1006/abio.1997.2032
Li, 1955, Some metal complexes of sulfur containing amino acids, J. Am. Chem. Soc., 77, 5225, 10.1021/ja01625a006
Li, 2004, Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice, J. Neurochem., 89, 1308, 10.1111/j.1471-4159.2004.02455.x
Li, 2006, Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress, Pharmacol. Res., 53, 6, 10.1016/j.phrs.2005.08.002
Marambaud, 2005, Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides, J. Biol. Chem., 280, 37377, 10.1074/jbc.M508246200
Mark, 1997, A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide, J. Neurochem., 68, 255, 10.1046/j.1471-4159.1997.68010255.x
Miller, 1995, Antioxidant activity of resveratrol in red wine, Clin. Chem., 41, 1789, 10.1093/clinchem/41.12.1789
Morris, 2002, Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study, J. Am. Med. Assoc., 287, 3230, 10.1001/jama.287.24.3230
Nathan, 2005, Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase, J. Exp. Med., 202, 1163, 10.1084/jem.20051529
Nourooz-Zadeh, 1999, F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease, J. Neurochem., 72, 734, 10.1046/j.1471-4159.1999.0720734.x
Ojaimi, 1999, Mitochondrial respiratory chain activity in the human brain as a function of age, Mech. Ageing Dev., 111, 39, 10.1016/S0047-6374(99)00071-8
Olivieri, 2001, N-acetyl-L-cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: effects on beta-amyloid secretion and tau phosphorylation, J. Neurochem., 76, 224, 10.1046/j.1471-4159.2001.00090.x
Pappolla, 1998, Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo, Am. J. Pathol., 152, 871
Pinto, 2005, Treatment of YAC128 mice and their wild-type littermates with cystamine does not lead to its accumulation in plasma or brain: implications for the treatment of Huntington disease, J. Neurochem., 94, 1087, 10.1111/j.1471-4159.2005.03255.x
Pratico, 2002, Alzheimer's disease and oxygen radicals: new insights, Biochem. Pharmacol., 63, 563, 10.1016/S0006-2952(01)00919-4
Pratico, 2000, Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity, Ann. Neurol., 48, 809, 10.1002/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9
Prokop, 2006, Resveratrol and its glycon piceid are stable polyphenols, J. Med. Food, 9, 11, 10.1089/jmf.2006.9.11
Ramassamy, 2000, Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain, Neurobiol. Dis., 7, 23, 10.1006/nbdi.1999.0273
Robb, 2008, Molecular mechanisms of oxidative stress resistance induced by resveratrol: Specific and progressive induction of MnSOD, Biochem. Biophys. Res. Commun., 367, 406, 10.1016/j.bbrc.2007.12.138
Sale, 2005, Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4′-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells, Int. J. Cancer, 115, 194, 10.1002/ijc.20884
Sano, 1997, A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study, N. Engl. J. Med., 336, 1216, 10.1056/NEJM199704243361704
Smith, 1991, Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A., 88, 10540, 10.1073/pnas.88.23.10540
Studer, 2001, N-Acetyl-L-cystein downregulates beta-amyloid precursor protein gene transcription in human neuroblastoma cells, Biogerontology, 2, 55, 10.1023/A:1010065103073
Wang, 2002, Resveratrol protects against global cerebral ischemic injury in gerbils, Brain Res., 958, 439, 10.1016/S0006-8993(02)03543-6